System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Neil J Greening is an expert in Pulmonology at University of Leicester (United Kingdom). As of October 2026, ScienceLeadR ranks Neil J Greening in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. Neil J Greening has authored 202 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 665 (community average: 125). How the SLR is computed.

LeadR Profile

Neil J Greening University of Leicester United Kingdom
665 ScienceLeadR Reputation 665

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Public Health - Infectiology - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

University of Leicester

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 202

Citations

Citations: 4 755 1st author: 11 Last author: 26 Unique author: 2

Main journals

01.02 - Rehabilitation and chronic care 25
Thorax 21
ERJ Open Res 15
medRxiv (Cold Spring Harbor Laboratory) 9
Chron Respir Dis 8

Best Journals

Lancet Respir Med 4
Lancet 1
Nat Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Validation of the General Practice Physical Activity Questionnaire after severe COVID-19.
PMID 42769819 — exercise, general practice, covid-19, sex		ERJ Open Res20260
Probable post-traumatic stress disorder following discharge from hospital with COVID-19: prospective cohort study.
PMID 42747038 — depression, stress disorders, post-traumatic, stress, physiological, cohort studies, covid-19, odds ratio, stress disorders, traumatic, risk factors, intensive care units, wounds and injuries		BJPsych Open20260
Interpreting Win Ratios in COPD From BOREAS and NOTUS.
PMID 42419851 — pulmonary disease, chronic obstructive		Chest20260
The systemic impact of acute exacerbations of COPD requiring hospitalisation: a narrative review.
PMID 42267363 — lung, pulmonary disease, chronic obstructive, therapeutics		ERJ Open Res20260
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPD.
PMID 42248680 — lung, pulmonary disease, chronic obstructive, research, therapeutics		Thorax20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 3
Recruiting 2
Unknown 1

By type:

Observational 4
Interventional 2

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 10

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The CATALINA Study
NCT05008081 — chronic disease, hospitalization, multiple chronic conditions, cohort studies, pulmonary disease, chronic obstructive, lung diseases, lung diseases, obstructive		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS